{
    "clinical_study": {
        "@rank": "131230", 
        "arm_group": {
            "arm_group_label": "Laparoscopic Vertical Gastroplasty", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "Evaluation of the laparoscopic approach of the Magenstrasse and Mill procedure in a\n      prospective study of 100 patients"
        }, 
        "brief_title": "Clinical Study of Laparoscopic Non Banded Vertical Gastroplasty in Bariatric Surgery", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Obesity", 
        "condition_browse": {
            "mesh_term": "Obesity"
        }, 
        "detailed_description": {
            "textblock": "The laparoscopy is performed under general anesthesia with a 5 ports access under 14mm Hg\n      pressure. After opening of the gastrocolic ligament and division of any adhesions between\n      stomach and pancreas a circular opening is performed at the junction of corpus and antrum of\n      the stomach with a circular stapler. A tubular gastric pouch is then created along a\n      calibration tube at the lesser curvature by a vertical stapling starting from the circular\n      opening to the angle of Hiss."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Assessment by a multidisciplinary team specialized in bariatric and metabolic surgery\n             including surgeon, endocrinologist, psychologist and/or psychiatrist, dietician\n\n          -  BMI>40\n\n          -  BMI>35 with diabetes or sleep apnea syndrome or hypertension treated with 3 drugs for\n             at least one year\n\n          -  Male or female patients between 18 and 75 years of age; fertile female patients must\n             use a reliable contraception method;\n\n          -  No previous bariatric procedure\n\n          -  Informed consent given by patient\n\n        Exclusion Criteria:\n\n          -  Medical contra-indication for a general anesthesia, or abdominal surgery (allergies\n             to anesthetic drugs, cardio-vascular, pulmonary, or renal conditions leading to an\n             unacceptable risk for the procedure\n\n          -  Psychological-Psychiatric (boulimia, severe depression, psychotic condition)\n\n          -  Non stabilized endocrine disorder, with potential interference on weight and/or\n             diabetic condition\n\n          -  Unability to understand goal of the study, plan of treatment and follow-up\n\n          -  Large hiatal hernia and/or severe esophageal reflux disease\n\n          -  Grazer, Sweet eater behavior"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 25, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050477", 
            "org_study_id": "B707201214181"
        }, 
        "intervention": {
            "arm_group_label": "Laparoscopic Vertical Gastroplasty", 
            "description": "The Magenstrasse and Mill procedure is a conservative vertical gastroplasty described in 1987 through a laparotomy. A tubular gastric pouch is created by a vertical stapling extending from the antrum to the angle of Hiss. In this study, we evaluate the laparoscopic technique of the procedure.", 
            "intervention_name": "Laparoscopic Vertical Gastroplasty", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity", 
            "Bariatric", 
            "Surgery", 
            "Sleeve", 
            "Gastroplasty", 
            "Laparoscopy"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Li\u00e8ge", 
                    "country": "Belgium", 
                    "zip": "4000"
                }, 
                "name": "Dept of Abdominal Surgery and Transplantation, CHU Li\u00e8ge"
            }
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_arms": "1", 
        "official_title": "Laparoscopic Non Banded Vertical (Magenstrasse and Mill) Gastroplasty In Bariatric Surgery. Morbidity and Results on Weight Loss and Associated Co-morbidities", 
        "overall_official": {
            "affiliation": "Dept of Abdominal Surgery and Transplantation CHU Li\u00e8ge Belgium", 
            "last_name": "Arnaud De Roover, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Morbidity/Mortality", 
                "safety_issue": "Yes", 
                "time_frame": "1 month"
            }, 
            {
                "description": "Evaluation at 1,3,6 and 12 months through clinical evaluation.", 
                "measure": "Effect of the procedure on weight loss", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050477"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital of Liege", 
            "investigator_full_name": "Arnaud De Roover", 
            "investigator_title": "Professeur de Clinique, Chef de Clinique", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Evaluation at 1,3,6 and 12 months through clinical evaluation, Gastroscopy if symptoms present. Upper GI opacification at one year will be performed for all patients.", 
                "measure": "Reflux disease", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "description": "Co-morbidities include diabetes, hypertension, sleep apnea syndrome, dyslipemia Evaluation at 1,3,6 and 12 months through clinical evaluation and blood assessment", 
                "measure": "Effect of procedure on obesity associated co-morbidities", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "University Hospital of Liege", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital of Liege", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}